City

Guangzhou (1)

Condition

Advanced Solid, Malignant Tumors (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Genzyme, a Sanofi Company (1)

Collaborator

Intervention

vandetanib (1)

vandetanib 300 mg (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

advanced solid, malignant tumors

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Solid, Malignant Tumors Trial in Guangzhou (Vandetanib, Vandetanib 300 mg)

Completed

Advanced Solid, Malignant Tumors

Vandetanib
Vandetanib 300 mg

Guangzhou, China

Research Site

Aug 29, 2016